1. Home
  2. HROW vs STRA Comparison

HROW vs STRA Comparison

Compare HROW & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$52.18

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

STRA

Strategic Education Inc.

HOLD

Current Price

$75.88

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
STRA
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HROW
STRA
Price
$52.18
$75.88
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
$68.86
$96.50
AVG Volume (30 Days)
474.2K
186.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
3.16%
EPS Growth
N/A
60.48
EPS
N/A
3.76
Revenue
N/A
$997,137,000.00
Revenue This Year
$38.82
$5.99
Revenue Next Year
$42.18
$3.79
P/E Ratio
N/A
$20.24
Revenue Growth
N/A
57.23
52 Week Low
$20.85
$72.17
52 Week High
$54.98
$102.54

Technical Indicators

Market Signals
Indicator
HROW
STRA
Relative Strength Index (RSI) 60.16 40.48
Support Level $48.73 $75.25
Resistance Level $50.98 $77.36
Average True Range (ATR) 2.38 3.11
MACD 0.55 -0.57
Stochastic Oscillator 93.54 30.67

Price Performance

Historical Comparison
HROW
STRA

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: